CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

The Medication Pass Nutritional Supplement Program in Patients Receiving Medication: A Review of Clinical Effectiveness and Guidelines

Last updated: March 25, 2015
Project Number: RC0644-000
Product Line: Rapid Response
Research Type: Devices and Systems
Report Type: Summary with Critical Appraisal
Result type: Report


  1. What is the clinical effectiveness of using the Medication Pass Nutritional Supplement program (Med-Pass) in patients receiving medication in an institutionalized setting?
  2. What are the evidence-based guidelines associated with the use of Med-Pass in patients receiving medication in an institutionalized setting?

Key Message

Evidence retrieved from one randomized controlled trial (RCT), two non-randomized comparative trials, four before-after studies and 2 clinical practice guidelines (CPGs) was in favor of clinical benefits due to Med-Pass in elderly hospitalized patients. However, limitations identified in the studies prevent us to draw a firm conclusion. As highlighted in a CPG based on a systematic review, high quality research is further needed for specific interventions of oral liquid supplementation.